India and the World after Covid-19: Climate Aspect
DOI:
Abstract
This research ponders over the climate aspect during the Covid 19. The purpose of this is too aware and disseminate the outbreak of covid 19 cases hiking in a sky rocketing way. This study will focus on the contents of covid 19 where people are battling to overcome the hazard happening around vicinity brought by climate aspect. Its consist of information and analysis of different countries, metamorphosis of the nature with its pulchritude, tactic that need to be followed to overcome predicament, major affected tribe, initiative by various countries, climate aspect, impact at utmost level, drastic change within a smidge, crucial steps to curb COVID-19. This is also fruitful to know the behavior of nature during the COVID-19 climate change. The data were obtained through various authorized news channel and worldometers.
Downloads
Views : 516
Downloads : 304
References
Q. Li, X. Guan, and P. Wu, “Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia,” The New England Journal Medicine, 2020. [Online]. Available: https:// www.nejm.org/doi/full/10.1056/nejmoa2001316 [Accessed: April.25, 2020].
C. Huang, Y. Wang, and X. Li, “Clinical features of patients infected with 2019 novel corona virus in Wuhan,” China Journal Lancet. [Online] Available: https:// pubmed.ncbi.nlm.nih.gov/31986264/ [Accessed: April. 25, 2020].
L. Xu, Y. Mao, and G. Chen, “Risk factors for severe corona virus disease 2019 (COVID-19).” [Online]. Available: https:// www.medrxiv.org/content/10.1101/2020.03.30.20047415v1.full.pdf [Accessed: Apri.25, 2020].
C. Wu, and M. D. Xiaoyan, “Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan,China,” JAMA Intern Med. Published. [Online]. Available: https:// pubmed.ncbi.nlm.nih.gov/32167524/ [Accessed: March.13, 2020].
D. S. Hui, T. A. Madani, and F. Ntoumi, “The continuing COVID-19 epidemic threat of novel coronaviruses to global health-The latest 2019 novel coronavirus outbreak in Wuhan, China,” International Journals of Infectious Diseases: IJID: official publication of the International Society for Infectious Diseases, 2020.
Anynomous, Virus Taxonomy, Classification and No-Menclature of Viruses: Ninth Report of the International Committee on Taxonomy of Viruses. San Diego, CA: Academic Press, 2012.
K. Dhama, S. Khan, and R. Tiwari, “Coronavirus Disease 2019–COVID-19,” Preprints, [Online]. Available: https:// www.preprints.org/manuscript/202003.0001/v1. [Accessed: March 13, 2020].
C. Geller, M. Varbanov, and E. Raphael, “Duval Human Coronaviruses: Insights into Environmental Resistance and Its Influence on the Development of New Antiseptic Strategies,” Viruses, vol. 4, pp. 3044-3068, 2012.
D. D. Richman, R.J Whitley and F.G Hayden, Clinical virology, 4th edition, Washington: ASM Press, 2016.
P.C Woo, and Y. Huang, “Coronavirus Genomics and Bioinformatics Analysis,” Viruses, vol. 2, 2010.
H. L. Quigley, and J.T Mateos, The resilience of the Spanish health system against the COVID-19 pandemic, Lancet Public Health. 2020. [Online]. Available: https: //doi.org/10.1016/S2468-2667 (20)30060-8. [Accessed: April. 25, 2020].
N. Kandel, S. Chungong, A. Omaar, and J. Xing, “Health security capacities in the context of COVID-19 outbreak: an analysis of International Health Regulations annual report data from 182 countries,” Lancet, 2020. [Online]. Available: https:// doi.org/10.1016/S0140-6736 (20)30553-5. [Accessed: April. 25, 2020].
R. R. Ayebare, R. Flick, and S. Okware, “Adoption of COVID-19 triage strategies for low-income settings,” Lancet Respir Med, 2020. [Online]. Available: https:// doi.org/10.1016/S2213-2600 (20)30114-4. [Accessed: April. 25, 2020].
G. Kampf, D. Todt, S. Pfaender, and E. Steinmann, “Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents,” Journal of Hospital Infection, vol. 104, pp. 246-251, 2020.
A. A. Elfiky, “Anti-HCV, nucleotide inhibitors, repurposing against COVID-19,” Life Sciences, 2020. [Online] Available: https:// doi.org/10.1016/j.lfs.2020.117477. [Accessed: April. 25, 2020].
C. M. Chu, V.C. Cheng, and I. F. Hung, “Role of lopinavir/ritonavir in the treatment of SARS: Initial virological and clinical findings,” Thorax, vol. 59, no. 3, pp. 252–256, 2004.
M. R. Loutfy, L. M Blatt, and K. A Siminovitch, “Interferon Alfacon-1 Plus Corticosteroids in Severe Acute Respiratory Syndrome: A Preliminary Study,” J Am Med Assoc, vol. 290 no. 24, pp. 3222–3228, 2003.
J.S.M Peiris, C. M. Chu, and V.C. Cheng, “Clinical Progression and Viral Load in A Community Outbreak of Coronavirus-Associated SARS Pneumonia: A Prospective Study,” Lancet, vol. 361 pp. 1767–1772, 2003.
I. S. Wang, B. Kang, and J. Ma, “A deep learning algorithm using CT images to screen for Corona Virus Disease (COVID-19),” MedRxiv, 2020. [Online]. Available: https:// doi.org/10.1101/2020.02.14.20023028. [Accessed: April. 25, 2020]
B. R. Beck, B.R., Shin, and B. Choi, “Predicting commercially available antiviral drugs that may act on the novel coronavirus (2019-nCoV), Wuhan, China through a drug-target interaction deep learning model,”BioRxiv, 2020. [Online]. Available: https:// doi.org/10.1101/2020.01.31.929547. [Accessed: April. 25, 2020].
J. Chen, L. Wu, and J. Zhang, “Deep learning-based model for detecting 2019 novel coronavirus pneumonia on 1 high-resolution computed tomography: a prospective study,” MedRxiv, 2020. [Online]. Available: https:// doi.org/10.1101/2020.02.25.20021568. [Accessed: April. 25, 2020].
